跳至主要内容
临床试验/ACTRN12610000311055
ACTRN12610000311055已完成未知

A pilot, randomised controlled trial of retinal artery flicker induced vasodilatation to detect change in endothelial function in participants with obstructive sleep apnoea treated with continuous postitive airway pressure for 6 weeks.

Austin Health Department of Cardiology and Institute for Breathing and Sleep0 个研究点目标入组 30 人开始时间: 2010年4月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Moderate to severe Obstructive Sleep Apnoea(OSA) - Apnoea Hypopnoea Index greater than or equal to 30, with associated hypoxaemia – Oxygen saturation(Sa O2) <90% for a minimumm of 6% of total sleep time.
  • Actual coronary artery disease or two or more of the following cardiovascular risk factors – hypertension, dyslipidaemia, diabetes, smoking, positive family history.

排除标准

  • Commercial driver or patients listed for urgent CPAP implementation.

研究者

发起方
Austin Health Department of Cardiology and Institute for Breathing and Sleep

相似试验